Recent Quotes

No recent quotes available.

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/16/2014

Company Name Symbol %Change
BITAUTO HOLD BITA
14.82%
ANI PHARMACE ANIP
14.66%
INTERACTIVE IBKR
11.69%
IMMUNOGEN IN IMGN
11.02%
E HOUSECHINA EJ
9.25%

View the PFP Archive

ZACKS
4 Duds in a Row

Yesterday I spoke about "3 strikes you're out" with a trio of weak economic reports (ISM Mfg, ISM Services and ADP Employment). Now add the worst Jobless Claims reading in months to the mix. That makes 4 duds in a row.

This means that a lot is riding on the Government Employment Situation report 8:30am Friday morning. Estimates stand at 193,000 jobs added for the month. That may be too much to ask for given the soft ADP showing.

I did not like the mojo coming into this report so I am now down to 60% long the market (after being north of 100% long all of 2013 with the help of leveraged ETFs). Meaning I expect the market to be ready for an extended consolidation period or even modest contraction in the near future.

That is just the short term picture. The long term bull is still in place until there is a real threat of a recession on the horizon (gladly that is not a serious concern). So traders should consider taking some profits and getting more defensive for a while. We will likely have a chance to buy aggressively on dips over the next few weeks.

Featured Commentaries:

•  3 Stocks Looking to Beat Estimates

•  Emerging Market ETFs for Growth & Income

•  Pharma & Biotech Stock Outlook - Apr 2013

Best,

Steve Reitmeister

Executive VP - Zacks.com

Zacks Investment Research

Follow Us:  

Sponsor

This Is Your Perfect Chance to See ALL Zacks' Picks

Given today's range-bound market, right now is the best time to claim full access to all of our private buy and sell recommendations. You'll even see the stocks that are so exclusive they've been closed to the public. What a perfect way to bolster your portfolio with the best short-term trades and long-term investments no matter what the market is doing.

Today, you can get thousands of dollars worth of services at a low price for 30 days. Plus, the picks are backed by the boldest guarantee we ever made.

See our latest stocks today >>

Bull & Bear of the Day

Zacks Rank #1 Strong Buy

International Paper (IP)

IP has been generating solid cash flows and rewarding the shareholders with growing dividends.

 

Zacks Rank #5 Strong Sell

Cablevision (CVC)

This cable television company is going through a challenging time due to rising costs and increased competition.


Stock Picking Strategies

Your Next Stock Should Be Making New Highs  ››

What's Keeping Bulls Awake at Night?  ››

Ahead of Wall Street  ››


Funds Commentary

Top 5 Zacks #1 Ranked Technology Mutual Funds  ››

Are Short Term Bond ETFs the New Safe Haven?  ››

Four ETFs to Buy on the Market Pullback  ››


Options Strategies

Why Some Have More 'Luck' in Options Than Others  ››


Video Reports

Market Perspectives

After a solid first quarter, Zacks experts weigh in on whether the market can fly higher from here.

Roundtable Top Picks for the Week of Apr. 1st

Opportunities in Auto Parts, Lodging and Mexico. Investments covered include Visteon Corp. (VC), Ashford Hospitality Trust (AHT) and ishares Mexico ETF (EWW).

Institutional Buying

Aggressive growth stocks seeing institutional buying discussed by Brian Bolan, Corrections Corp (CXW) and Trulia (TRLA).

Sponsor

What's Today's Top Rated Mutual Fund?

Use the Zacks Mutual Fund Rank, a quantitative ratings system designed to help you find the best funds to beat the market. See which ones to buy, which to sell and track your favorite mutual fund family.

Get started now>>


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.